Search results for: Innovation Policy Prize
Filter search results
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
OHE Consulting has produced a report summarising the literature on indication-based pricing and how it has been applied in the U.S. and 5 European countries. OHE Consulting has produced a…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
OHE Consulting produces a report critiquing a paper by Hill et al. (2018) on estimated costs of production for the WHO Essential Medicines List. This OHE Consulting Report, published today,…
Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS
29 August 2018
OHE Consulting produces a report on Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS. This OHE Consulting Report, published today, reviews “Measurement of Medicines Expenditure in the…
Private Provision of Publicly Funded Health Care: The Economics of Ownership
10 September 2018
…reduce waiting times and drive innovation and efficiency improvements. Depending on the viewpoint, private ownership is either a disaster or a salvation for the NHS. A new OHE Briefing, by…
OHE Lunchtime Seminars: Steven Pearson and Janel Hanmer
4 October 2018
…be able to manage a growing number of drugs offering potential cures for a wide range of illnesses. The innovation pipeline includes potential cures for haemophilia, sickle cell disease, and…
Securing Funds for the Proposed NHS Multi-year Funding: The Feasibility of Using a Hypothecated Tax
24 October 2018
…of Health Economics. Sampson, C., O’Neill, P. and Lorgelly, P. (2018) The Impact of New Medicines in the NHS: 70 Years of Innovation. London: Office of Health Economics. …
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
Multi-Indication Pricing: Practical Solutions and Steps to Move Forward. A summary of an HTAi panel session. We have just published a new OHE Briefing entitled ‘Multi-Indication Pricing: Practical Solutions and…
Around The World in HTAs: Greece – Late but with an Optimistic Future
18 October 2023
…are still a few concerns regarding its structure, the assessment criteria in its clinical parameters, and the prioritization of medicines based on specific parameters such as degree of innovation. There…
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
11 July 2023
…the discussion around dementia policy high in political agendas. Particularly, policies addressing the unmet needs of people living with dementia and a framework supporting informal carers both mentally and financially should be…